Log In
Print
BCIQ
Print
Print this Print this
 

PNT2258

Also known as: PNT100

  Manage Alerts
Collapse Summary General Information
Company ProNAi Therapeutics Inc.
Description24-base phosphodiester DNA sequence targeting the B cell lymphoma 2 (BCL-2; BCL2) gene formulated with Marina's Smarticles liposomal delivery technology
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear DNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today